Center-Authored Papers

Filters: Author is de Koning, Harry J  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
E
Etzioni R, Gulati R, Tsodikov A, Wever EM, Penson DF, Heijnsdijk EAM, Katcher J, Draisma G, Feuer EJ, de Koning HJ et al..  2012.  The prostate cancer conundrum revisited : Treatment changes and prostate cancer mortality declines.. Cancer. Abstract
G
Gulati R, Wever EM, Tsodikov A, Penson DF, Inoue LYT, Katcher J, Lee S-Y, Heijnsdijk EAM, Draisma G, de Koning HJ et al..  2011.  What if i don't treat my PSA-detected prostate cancer? Answers from three natural history models. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(5):740-50. Abstract
Gulati R, Tsodikov A, Wever EM, Mariotto AB, Heijnsdijk EAM, Katcher J, de Koning HJ, Etzioni R.  2012.  The impact of PLCO control arm contamination on perceived PSA screening efficacy.. Cancer causes & control : CCC. 23(6):827-35. Abstract
H
Han SS, Ten Haaf K, Hazelton WD, Munshi VN, Jeon J, Erdogan SA, Johanson C, McMahon PM, Meza R, Kong CY et al..  2017.  The impact of overdiagnosis on the selection of efficient lung cancer screening strategies.. International journal of cancer. Abstract
K
de Koning HJ, Meza R, Plevritis SK, Ten Haaf K, Munshi VN, Jeon J, Erdogan SA, Kong CY, Han SS, van Rosmalen J et al..  2013.  Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force.. Annals of internal medicine. Abstract
L
Lansdorp-Vogelaar I, Gulati R, Mariotto AB, Schechter CB, de Carvalho TM, Knudsen AB, van Ravesteyn NT, Heijnsdijk EAM, Pabiniak C, van Ballegooijen M et al..  2014.  Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.. Annals of internal medicine. 161(2):104-12. Abstract
M
McMahon PM, Meza R, Plevritis SK, Black WC, Tammemagi MC, Erdogan A, Ten Haaf K, Hazelton W, Holford TR, Jeon J et al..  2014.  Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the national lung screening trial using comparative modeling.. PloS one. 9(6):e99978. Abstract
Meza R, Ten Haaf K, Kong CY, Erdogan A, Black WC, Tammemagi MC, Choi SE, Jeon J, Han SS, Munshi V et al..  2014.  Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials.. Cancer. Abstract
Miglioretti DL, Lange J, van den Broek JJ, Lee CI, van Ravesteyn NT, Ritley D, Kerlikowske K, Fenton JJ, Melnikow J, de Koning HJ et al..  2016.  Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study.. Annals of internal medicine. 164(4):205-14. Abstract
Moolgavkar SH, Holford TR, Levy DT, Kong CY, Foy M, Clarke L, Jeon J, Hazelton WD, Meza R, Schultz F et al..  2012.  Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000.. Journal of the National Cancer Institute. 104(7):541-8. Abstract
S
Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ, Miglioretti DL, Mandelblatt JS et al..  2015.  Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.. Annals of internal medicine. 162(3):157-66. Abstract
T
Tsao AS, Scagliotti GV, Bunn PA, Carbone DP, Warren GW, Bai C, de Koning HJ, Yousaf-Khan UA, McWilliams A, Tsao MS et al..  2016.  Scientific Advances in Lung Cancer 2015.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. Abstract
Tsodikov A, Gulati R, de Carvalho TM, Heijnsdijk EAM, Hunter-Merrill RA, Mariotto AB, de Koning HJ, Etzioni R.  2017.  Is prostate cancer different in black men? Answers from 3 natural history models. Cancer. Abstract
Tsodikov A, Gulati R, Heijnsdijk EAM, Pinsky PF, Moss SM, Qiu S, de Carvalho TM, Hugosson J, Berg CD, Auvinen A et al..  2017.  Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.. Annals of internal medicine. Abstract